Intercept Pharmaceuticals ICPT
$ 19.0
0.0%
Quarterly report 2023-Q3
added 11-06-2023
Intercept Pharmaceuticals ROE Ratio 2011-2024 | ICPT
Annual ROE Ratio Intercept Pharmaceuticals
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|
-22.37 | 19.72 | 164.74 | -668.56 | -1616.53 | -2199.24 | -131.09 | -37.6 | -122.67 | -82.27 | -66.21 | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
164.74 | -2199.24 | -432.92 |
Quarterly ROE Ratio Intercept Pharmaceuticals
2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
187.99 | 440.26 | 450.98 | 255.07 | 257.4 | 11.34 | 14.76 | 28.0 | 59.25 | 96.76 | 129.23 | 164.74 | -56.9 | -261.28 | -437.74 | -668.56 | -938.2 | -1110.58 | -1365.12 | -1616.53 | -1835.56 | -1941.7 | -2076.92 | -2199.24 | -1558.29 | -1143.42 | -639.68 | -131.09 | -107.62 | -87.88 | -71.29 | -37.6 | -38.03 | -45.1 | -22.65 | -122.67 | -122.59 | -145.58 | -176.43 | -82.27 | -113.82 | -83.18 | -74.54 | -66.21 | 122.78 | 241.63 | 249.34 | 142.43 | 110.98 | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
450.98 | -2199.24 | -335.01 |